2024 Peritoneal Mesothelioma Treatment Updates

On Tuesday, July 16, at 6 p.m. ET, The Mesothelioma Center at Asbestos.com will host a webinar open to all peritoneal mesothelioma patients, their families and caregivers. Our webinar will focus on the latest treatment advances and clinical trials for peritoneal mesothelioma in 2024.

Only 1 out of 5 mesothelioma cases are the peritoneal type, which develops in the abdomen. Peritoneal mesothelioma affects the tissue lining, surrounding and connecting sensitive organs, such as the liver and kidneys, called the peritoneum.

Dr. Edward Levine, a nationally recognized HIPEC specialist, will discuss the newest developments in treating peritoneal cancer. Tamron Little, a 17-year mesothelioma survivor, will share her personal journey from diagnosis to today.

After the presentation, Dr. Levine and Tamron will answer your questions in a live Q&A. If you’re unable to attend our live webinar, registering will guarantee you receive a recording after the event.

Discover 2024 Peritoneal Mesothelioma Treatment Standards

The current standard for peritoneal mesothelioma surgery is hyperthermic intraperitoneal chemotherapy or HIPEC. Not everyone is eligible for this aggressive surgery, however. Your individual eligibility depends on factors such as coexisting conditions and your overall health. 

In this webinar, Dr. Levine will discuss the latest updates in peritoneal mesothelioma care, from surgical standards to chemotherapy drugs. He’ll also share current and upcoming clinical research trials pushing the boundaries of contemporary treatment and improving patient outcomes.

Throughout the presentation, Tamron Little will share her experiences with HIPEC and other peritoneal mesothelioma treatments. She’ll answer your questions, discuss her feelings about treatment developments and share tips and insights from her own personal experiences with you.

Who Should Attend?

You should attend if you or a loved one have been diagnosed with peritoneal mesothelioma. We encourage anyone looking for information on peritoneal mesothelioma treatment or information about currently enrolling clinical trials across the United States to attend. 

This webinar will be of value to you if you have questions about new treatment options in 2024, peritoneal mesothelioma symptoms, clinical trials or finding the right doctor and treatment center for you. Dr. Levine and Tamron look forward to providing an overview of 2024 treatment updates and addressing any concerns you may have.

About the Experts

Dr. Edward Levine

Dr. Edward Levine is a renowned specialist in treating peritoneal malignancies, particularly mesothelioma. He serves as the chief of surgical oncology services at Wake Forest Baptist Medical Center Comprehensive Cancer Center in Winston-Salem, North Carolina. 

He is recognized for his innovative treatment approach, which involves cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. HIPEC has significantly improved patient outcomes in recent years.

Dr. Levine’s clinical interests extend to stomach, breast, liver and esophageal cancers, melanoma, and other gastrointestinal malignancies. In addition to his clinical duties, he is a professor of surgical oncology. Levine has been part of Wake Forest Baptist Medical Center since 1998 and has led numerous clinical trials to enhance treatment protocols.

Tamron Little

Webinar co-presenter Tamron Little was diagnosed with peritoneal mesothelioma in 2007. She raises public awareness about the disease and has years of experience helping patients and their families navigate this rare and devastating cancer.

Tamron was diagnosed with peritoneal mesothelioma when she was 21 years old and pregnant with her first child. Following the birth of her son Caleb, she underwent cytoreductive surgery with HIPEC and intensity-modulated radiation therapy.
Now, she shares her firsthand experiences with patients and provides a unique perspective on what it’s like to be a mesothelioma survivor. Her stories have been invaluable to peritoneal mesothelioma patients seeking support and inspiration.